Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | SVP and CFO | February 12, 2026 | February 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 206,037 |
Last balance in matching sequence
After 2026-02-15 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-02-15 · Exercise / conversion · Acquired 14,999 · Balance 211,827 F1: On February 15, 2023, the reporting person was granted 45,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. F2: Owned jointly with reporting person's wife. Row 2 · 2026-02-15 · Tax withholding · Disposed 5,790 · Balance 206,037 F2: Owned jointly with reporting person's wife. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-15 · Exercise / conversion · Disposed 14,999 · Balance 0 F1: On February 15, 2023, the reporting person was granted 45,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2026-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-12 · Grant · Acquired 25,000 · Balance 25,000 F4: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2036-02-12 | Direct | 150,000 |
Reported balance
After 2026-02-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-12 · Grant · Acquired 150,000 · Balance 150,000 F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 15, 2023, the reporting person was granted 45,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2: Owned jointly with reporting person's wife.
F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
F4: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2019 Filed Jan 10, 2019 20:58 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,314 | $0.94 | $4,995.16 |
DisclosureSEC source: 0001125345-19-000004 · wf-form4_154715391380526.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000111 · wf-form4_154533982610455.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,314 Underlying: Common Stock · 5,000 shares Expires 2019-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:04 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | $0.94 | $4,700.00 |
DisclosureSEC source: 0001125345-18-000111 · wf-form4_154533982610455.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| November 27, 2018 Filed Nov 27, 2018 21:44 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000105 · wf-form4_154335506381111.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 3,000 shares Expires 2019-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transaction represents an exercise and hold of expiring options. Read SEC document |
| November 27, 2018 Filed Nov 27, 2018 21:44 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000105 · wf-form4_154335506381111.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 23:46 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 5,000 | $31.00 | $155,000.00 |
DisclosureSEC source: 0001125345-18-000049 · wf-form4_152046638490230.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,847 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017. F2 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:25 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000047 · wf-form4_152037509666671.xml · derivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-03-02 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 6,516 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000008 · wf-form4_151631397852775.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,516 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 6,516 | $0.94 | $6,125.04 |
DisclosureSEC source: 0001125345-18-000008 · wf-form4_151631397852775.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 16:59 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 3,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000002 · wf-form4_151499874004997.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,516 Underlying: Common Stock · 3,000 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 16:59 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 3,000 | $0.94 | $2,820.00 |
DisclosureSEC source: 0001125345-18-000002 · wf-form4_151499874004997.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:54 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-17-000097 · wf-form4_150481765495153.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,516 Underlying: Common Stock · 5,000 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 20:54 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | $0.94 | $4,700.00 |
DisclosureSEC source: 0001125345-17-000097 · wf-form4_150481765495153.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantCommon Stock · Derivative | 55,000 | $20.53 Strike: $20.53 | $1,129,150.00 |
DisclosureSEC source: 0001125345-17-000035 · wf-form4_148728515999230.xml · derivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2027-02-15 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| January 25, 2017 Filed Jan 26, 2017 21:36 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001125345-17-000016 · wf-form4_148546658457123.xml · derivative · entry 2 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,516 Underlying: Common Stock · 5,000 shares Expires 2018-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2017 Filed Jan 26, 2017 21:36 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | $0.94 | $4,700.00 |
DisclosureSEC source: 0001125345-17-000016 · wf-form4_148546658457123.xml · nonDerivative · entry 1 Karrels James · CIK 0001587477 · SVP, CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Owned jointly with reporting person's wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.